Marketable Securities and Fair Value Measurements (Tables)

12 Months Ended

Dec. 31, 2025

Debt Securities [Abstract]

Schedule of Marketable Securities

The following table summarizes the Company’s marketable securities (in thousands):

	December 31, 2025								December 31, 2024
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value		Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
Marketable securities:
Corporate debt securities	$	6,991	$	6	$	—	$	6,997	$	110,820	$	91	$	(204)	$	110,707
U.S. Treasury notes	103,620		813		(1)		104,432		101,059		184		(213)		101,030
	$	110,611	$	819	$	(1)	$	111,429	$	211,879	$	275	$	(417)	$	211,737

The following table summarizes the Company’s marketable securities maturity as of December 31, 2025 (in thousands):

Year	Amortized Cost		Fair Value
2026	$	58,021	$	58,275
2027	27,973		28,248
2028	24,617		24,906
	$	110,611	$	111,429

Schedule of Marketable Securities, Unrealized Loss Position

The following table summarizes the Company’s marketable securities with gross unrealized losses by security type aggregated by the length of time the investments have been in a continuous unrealized loss position as of December 31, 2025 (in thousands):

	Less Than 12 Months				12 Months or Greater
	Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses
Marketable securities:
Corporate debt securities	$	—	$	—	$	—	$	—
U.S. Treasury notes	12,932		1		—		—
	$	12,932	$	1	$	—	$	—

The following table summarizes the Company’s marketable securities with gross unrealized losses by security type aggregated by the length of time the investments have been in a continuous unrealized loss position as of December 31, 2024 (in thousands):

	Less Than 12 Months				12 Months or Greater
	Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses
Marketable securities:
Corporate debt securities	$	—	$	—	$	73,128	$	204
U.S. Treasury notes	25,295		104		38,787		109
	$	25,295	$	104	$	111,915	$	313

Schedule of Fair Value Assets Measured on Recurring Basis

The table below summarizes the Company’s financial instruments measured at fair value on a recurring basis (in thousands):

	December 31, 2025						December 31, 2024
	Level 1		Level 2		Level 3		Level 1		Level 2		Level 3
Marketable securities:
Corporate debt securities	$	—	$	6,997	$	—	$	—	$	110,707	$	—
U.S. Treasury notes	104,432		—		—		101,030		—		—
	$	104,432	$	6,997	$	—	$	101,030	$	110,707	$	—